Safety and efficacy of 'Dusting and Pop-dusting' with high power laser for treatment of large stones with ureteroscopy and lasertripsy (URSL): Prospective outcomes from a university teaching hospital.


Journal

Journal of endourology
ISSN: 1557-900X
Titre abrégé: J Endourol
Pays: United States
ID NLM: 8807503

Informations de publication

Date de publication:
07 Feb 2024
Historique:
medline: 7 2 2024
pubmed: 7 2 2024
entrez: 7 2 2024
Statut: aheadofprint

Résumé

The wide use of high-power laser has changed the landscape of ureteroscopy and lasertripsy (URSL). We wanted to look at the role and outcomes of high power Ho:YAG laser for URSL in paediatric stone disease. A prospective analysis of consecutive paediatric patients treated with 'Dusting and Pop-dusting' using a high-power laser was done between January 2016 to March 2022. The project was registered with our audit committee. Data was analysed for patient demographics, stone characteristics, operative details, procedural outcomes and complications. Stone free rate (SFR) was defined as fragments ≤2 mm on post-op ultrasound imaging 2-3 months after the procedure. A total of 35 patients underwent 43 procedures (1.2 procedure/patient) during the study period with a mean age of 9.4 years (range:1-16 years) and a male:female ratio of 13:22. The stone location was in the kidney in 32 (91.4%) patients of which 8 were in multiple renal locations. The mean stone size was 18 mm (range:10-39mm), with the pre and post stent rates of 37% and 56% respectively. An access sheath was used in 19 (44%) procedures. The overall stone free rate (SFR) on ultrasound scan was 94% (n=33) with no procedural complications noted in our series and a mean length of stay of 0.9 days. Paediatric URSL using a high-power laser achieves a high SFR even for large and multiple renal stones with no complications noted in our prospective series. Parents must however be counselled about the need for staged procedures which might be needed for large stones.

Identifiants

pubmed: 38323560
doi: 10.1089/end.2023.0150
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Auteurs

Bhaskar K Somani (BK)

University Hospital Southampton NHS Foundation Trust, 7425, Urology, Southampton, United Kingdom of Great Britain and Northern Ireland; bhaskarsomani@yahoo.com.

Virginia Massella (V)

University Hospital Southampton NHS Foundation Trust, 7425, Urology, Southampton, Southampton , United Kingdom of Great Britain and Northern Ireland; vi_m@hotmail.com.

Amelia Pietropaolo (A)

University Hospital Southampton NHS Foundation Trust, 7425, Urology, Southampton, United Kingdom of Great Britain and Northern Ireland; ameliapietr@gmail.com.

Francesco Ripa (F)

Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, 9339, Urology, Milan, Lombardia, Italy; f.ripa92@gmail.com.

Mrigyanka Sinha (M)

University Hospital Southampton NHS Foundation Trust, 7425, Urology, Southampton, United Kingdom of Great Britain and Northern Ireland; mrigankamani@gmail.com.

Stephen Griffin (S)

University Hospital Southampton NHS Foundation Trust, 7425, Paediatric Urology, Southampton, United Kingdom of Great Britain and Northern Ireland; stephengriffin@doctors.org.uk.

Classifications MeSH